About Aridis Pharmaceuticals, Inc. (adapted from Aridis Pharmaceuticals, Inc. prospectus):
They are a late-stage biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.